glp 1 microdosing for autoimmune Association between diseases and glucagon-like peptide-1 receptor agonists: A real-world evidence study GLP-1 Genetics: How Genes Affect

This suggests the eventual prescribing approach may involve reaching a target weight and then adjusting the dose downward to maintain it, rather than stopping treatment entirely

Certain patients, such as those who are actively increasing their dose or have other conditions that may delay gastric emptying, may need to stop taking the medication in advance to avoid increased risks during anesthesia

Berberine is not recommended during pregnancy due to potential risks to the fetus and concerns about neonatal jaundice from displacement of bilirubin, which could lead to kernicterus

This is why prioritizing small, regular, protein-rich snacks is essential

Ethics declarations Competing interests The authors declare no competing interests

GLP-1 medications have generally been well-tolerated for long-term use, though they may have mild to moderate side effects such as nausea, vomiting, diarrhea, abdominal discomfort, or occasional constipation